跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 199 条关于
“CD138”
全部
199
临床试验
112
药物
72
机构
0
资讯
15
去年
Nammi Therapeutics Initiates Phase I Trial of QXL138AM for Advanced Cancers and Multiple Myeloma
去年
Nammi Therapeutics Initiates Phase 1 Trial of QXL138AM in Advanced Solid Tumors and Multiple Myeloma
2个月前
PYGO2 Identified as Key Driver of 1q21+ Multiple Myeloma Progression and Potential Therapeutic Target
去年
HDP-101 Shows Promise in Relapsed/Refractory Multiple Myeloma
2年前
CD137-Targeted Therapies Show Promise in Cancer Immunotherapy
7个月前
CD137 Targeted Therapies Advance with 90 Clinical Trials Spanning Multiple Cancer Types
去年
2D4 Monoclonal Antibody Shows Promise in Treating Systemic Lupus Erythematosus by Targeting CD132
去年
Johnson & Johnson Declines Option for Genmab's HexaBody-CD38 Despite Promising Clinical Data
去年
Y-mAbs Presents Preclinical Pharmacokinetics Data for CD38-SADA Pretargeted Radioimmunotherapy at AACR 2025
去年
CASI Pharmaceuticals Names David Cory CEO to Advance Anti-CD38 Antibody CID-103 Program
第 1 页,共 2 页
上一页
下一页